Vetinnova
REFERENCE WEBSITE ON RESEARCH,
DEVELOPMENT AND INNOVATION IN ANIMAL HEALTH
CREATE PROJECT PROPOSALS

Acceso Usuarios
 

Área Personal

Acceso al área privada de la web
Search Partner Service

In this section, you can add new consortium or search for partners or R&D&i project proposals in Animal Health that are already defined or in their initial stage. The scope of the projects can be national, European or international calls, or private projects.

Superior Th1 polarizing adjuvant

Potent alfa galactosyl ceramide analogues targeting invariant natural killer T-cells (iNKT) for selective boosting of cellular immunity.Best-in-class when benchmarked to other Th1-skewing Galcer analogues (IL-12/IFNg/IL-4 profiles). Less IL-4 production compared to aGalCer. No acute toxicity. Druggable profile and optimized for easy synthesis.Proof of conceptEnhanced primary and boosted CD8+ Tcell responses in immunised mice.

Novel class of superior Th1 polarizing glycolipids valuable as vaccine adjuvant or adjuvant therapy in oncology.

Sven Arnouts
sven.arnouts@ugent.be
+32 495 707 334

volver
Una iniciativa de

Vet + i
Ayuda PTR2022-001249 financiada por:

UNION EUROPEA - FONDO EUROPEO DE DESARROLLO REGIONAL